Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants

International Journal of Pharmaceutics

Volumn 386, Issue 1-2, 2010, Pages 23-29

  Li, Changyan ^a   Cheng, Liang ^a   Zhang, Yaqiong ^a   Guo, Shengrong ^a   Wu, Weiping ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b National Institute for Parasitic Diseases   (China)

Author keywords

Cylindrical implant; Drug release; Poly( caprolactone); Praziquantel; Scanning electron microscope

Indexed keywords

POLYCAPROLACTONE; PRAZIQUANTEL;

ARTICLE; DIFFUSION; DRUG IMPLANT; DRUG RELEASE; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANTHELMINTICS; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DRUG COMPOUNDING; DRUG IMPLANTS; KINETICS; MODELS, CHEMICAL; MOLECULAR WEIGHT; POLYESTERS; PRAZIQUANTEL; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 74149083974     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.10.046     Document Type: Article

References (29)

1. Barbato F., La Rotonda M.I., Maglio G., Palumbo R., and Quaglia F. Biodegradable microspheres of novel segmented poly(ether-ester-amide)s based on poly(ε-caprolactone) for the delivery of bioactive compounds. Biomaterials 22 (2001) 1371-1378
2. Bruce L.D., Shah N.H., Waseem Malick A., Infeld M.H., and McGinity J.W. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid. Eur. J. Pharm. Biopharm. 59 (2005) 85-97
3. Chawla J.S., and Amiji M.M. Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int. J. Pharm. 249 (2002) 127-138
4. Cheng L., Guo S., and Wu W. Characterization and in vitro release of praziquantel from poly(ε-caprolactone) implants. Int. J. Pharm. 377 (2009) 112-119
5. Dinora G.E., Julio R., Nelly C., Lilian Y.M., and Cook H.J. In vitro characterization of some biopharmaceutical properties of praziquantel. Int. J. Pharm. 295 (2005) 93-99
6. Dong H., Li Y., Cai S., Zhuo R., Zhang X., and Liu L. A facile one-pot construction of supramolecular polymer micelles from α-cyclodextrin and poly(ε-caprolactone). Angew. Chem. Int. Ed. 47 (2008) 5573-5576
7. Fialho S.L., Behar-Cohen F., and Silva-Cunha A. Dexamethasone-loaded poly(ε-caprolactone) intravitreal implants: a pilot study. Eur. J. Pharm. Biopharm. 68 (2008) 637-646
8. Gou M., Zheng L., Peng X., Men K., Zheng X., Zeng S., Guo G., Luo F., Zhao X., Chen L., Wei Y., and Qian Z. Poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro. Int. J. Pharm. 375 (2009) 170-176
9. Gou M., Zheng X., Men K., Zhang J., Wang B., Lv L., Wang X., Zhao Y., Luo F., Chen L., Zhao X., Wei Y., and Qian Z. Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm. Res. 26 (2009) 2164-2173
10. Hombreiro Pérez M., Zinutti C., Lamprecht A., Ubrich N., Astier A., Hoffman M., Bodmeier R., and Maincent P. The preparation and evaluation of poly(ε-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J. Control. Release 65 (2000) 429-438
11. Jia W., Gu Y., Gou M., Dai M., Li X., Kan B., Yang J., Song Q., Wei Y., and Qian Z. Preparation of biodegradable polycaprolactone/poly(ethylene glycol)/polycaprolactone (PCEC) nanoparticles. Drug Deliv. 15 (2008) 409-416
12. Koizumi T., Ueda M., Kakemi M., and Kameda H. Rate of release of medicaments from ointment bases containing drugs in suspension. Chem. Pharm. Bull. 23 (1975) 3288-3292
13. Moore J.W., and Flanner H.H. Mathematical comparison of dissolution profiles. Pharm. Technol. 20 (1996) 64-74
14. Quinten T., Beer T.D., Vervaet C., and Remon J.P. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets. Eur. J. Pharm. Biopharm. 71 (2009) 145-154
15. Repka M.A., Gutta K., Prodduturi S., Munjal M., and Stodghill S.P. Characterization of cellulosic hot-melt extruded films containing lidocaine. Eur. J. Pharm. Biopharm. 59 (2005) 189-196
16. Ritger P.L., and Peppas N.A. A simple equation for desciption of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release 5 (1987) 23-36
17. Rosenberg R., Devenney W., Siegel S., and Dan N. Anomalous release of hydrophilic drugs from poly(ε-caprolactone) matrices. Mol. Pharm. 4 (2007) 943-948
18. Rothen-Weinhold A., Besseghir K., Vuaridel E., Sublet E., Oudry N., Kubel F., and Gurny R. Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants. Eur. J. Pharm. Biopharm. 48 (1999) 113-121
19. Siegel S.J., Kahn J.B., Metzger K., Winey K.I., Werner K., and Dan N. Effect of drug type on the degradation rate of PLGA matrices. Eur. J. Pharm. Biopharm. 64 (2006) 287-293
20. Siepmann J., and Göpferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv. Drug Deliv. Rev. 48 (2001) 229-247
21. Sinha V.R., Bansal K., Kaushik R., Kumria R., and Trehan A. Poly-ε-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 278 (2004) 1-23
22. Sotelo J., Del Brutto O.H., Penagos P., Escobedo F., Torres B., Rodriguez-Carbajal J., and Rubio-Donnadieu F. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J. Neurol. 237 (1990) 69-72
23. Sung K.C., Han R.Y., Hu O.Y.P., and Hsu L.R. Controlled release of nalbuphine prodrugs from biodegradable polymeric matrices: influence of prodrug hydrophilicity and polymer composition. Int. J. Pharm. 172 (1998) 17-25
24. Trey S.M., Wicks D.A., Mididoddi P.K., and Repka M.A. Delivery of itraconazole from extruded HPC films. Drug Dev. Ind. Pharm. 33 (2007) 727-735
25. Van Melkebeke B., Vermeulen B., Vervaet C., and Remon J.P. Melt granulation using a twin-screw extruder: a case study. Int. J. Pharm. 326 (2006) 89-93
26. Verhoeven E., Vervaet C., and Remon J.P. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 63 (2006) 320-330
27. Wang S., and Guo S. Disodium norcantharidate-loaded poly(ε-caprolactone) microspheres. II. Modification of morphology and release behavior. Int. J. Pharm. 353 (2008) 15-20
28. Wei X., Gong C., Shi S., Fu S., Men K., Zeng S., Zheng X., Gou M., Chen L., Qiu L., and Qian Z. Self-assembled honokiol-loaded micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymer. Int. J. Pharm. 369 (2009) 170-175
29. Zhang Y., Guo S., and Huang W. Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agent. Int. J. Pharm. 369 (2009) 19-23